CA
CL icon

Capitolis Advisors’s Colgate-Palmolive CL Stock Holding History

Capitolis Advisors’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-142,550
Closed -$12.2M – 212
2021
Q4 		$12.2M Hold
142,550
– – 0.07% 195
2021
Q3 		$10.7M Sell
142,550
-16,150
-10% -$1.28M 0.1% 159
2021
Q2 		$12.9M Buy
158,700
+122,229
+335% +$9.99M 0.15% 144
2021
Q1 		$2.88M Sell
36,471
-13,482
-27% -$1.06M 0.05% 218
2020
Q4 		$4.27M Buy
+49,953
New +$4.13M 0.07% 218

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capitolis Advisors's CL Position: Q1 2022 in Review

Capitolis Advisors sold out of Colgate-Palmolive (CL) in Q1 2022, closing a stake of 142,550 shares — an estimated $12.2M sold.

Capitolis Advisors first reported a position in CL in Q4 2020 and held it in 5 quarters. The position peaked at $12.9M in Q2 2021. 1,632 funds tracked by Wall St. Rank hold CL as of Q1 2022.

  • Capitolis Advisors reported no remaining Colgate-Palmolive position as of Q1 2022 after selling out during the quarter.
  • Capitolis Advisors sold 142,550 Colgate-Palmolive shares in Q1 2022, an estimated $12.2M.
  • Capitolis Advisors first reported a position in Colgate-Palmolive in Q4 2020 and held it in 5 quarters.
  • Capitolis Advisors's Colgate-Palmolive position peaked at $12.9M in Q2 2021.
  • 1,632 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2022.

Based on Capitolis Advisors's 13F filing for Q1 2022, filed 12 May 2022.